Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.

[1]  S. Curley,et al.  The role of surgery and adjuvant therapy in lymph node–positive cancers of the gallbladder and intrahepatic bile ducts , 2018, Cancer.

[2]  M. Kudo,et al.  Report of the 19th follow‐up survey of primary liver cancer in Japan , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  M. Kudo,et al.  General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan , 2015, Digestive Diseases.

[4]  G. Spolverato,et al.  The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma , 2015, Annals of Surgical Oncology.

[5]  G. Spolverato,et al.  Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration , 2015, Annals of Surgical Oncology.

[6]  Z. Hamady,et al.  One-Millimeter Cancer-Free Margin Is Curative for Colorectal Liver Metastases: A Propensity Score Case-Match Approach , 2014, Annals of surgery.

[7]  Celia P. Corona-Villalobos,et al.  Multidisciplinary approaches to intrahepatic cholangiocarcinoma , 2013, Cancer.

[8]  Natalia,et al.  Cholangiocarcinoma , 2010, Surgical Challenges in the Management of Liver Disease.

[9]  S. Giulini,et al.  Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. , 2012, Archives of surgery.

[10]  O. Farges,et al.  Influence of Surgical Margins on Outcome in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Study by the AFC-IHCC-2009 Study Group , 2011, Annals of surgery.

[11]  M. Rugge,et al.  Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization , 2011, Hepatology.

[12]  M. Choti,et al.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Pruvot,et al.  AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma , 2011, Cancer.

[14]  T. Takada,et al.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2011, Journal of hepato-biliary-pancreatic sciences.

[15]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[16]  E. Hamdy,et al.  Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver , 2010, Langenbeck's Archives of Surgery.

[17]  S. Woo,et al.  Survival Analysis of Intrahepatic Cholangiocarcinoma After Resection , 2010, Annals of Surgical Oncology.

[18]  K. McMasters,et al.  Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: A multicenter analysis , 2010, Journal of surgical oncology.

[19]  A. Ruzzenente,et al.  Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection , 2009, World Journal of Surgery.

[20]  U. Neumann,et al.  Extended Liver Resection for Intrahepatic Cholangiocarcinoma: A Comparison of the Prognostic Accuracy of the Fifth and Sixth Editions of the TNM Classification , 2009, Annals of surgery.

[21]  R. Adam,et al.  R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? , 2008, Annals of surgery.

[22]  T. Gruenberger,et al.  Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.

[23]  I. Endo,et al.  Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.

[24]  M. Makuuchi,et al.  Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan † , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[25]  T. Gruenberger,et al.  Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases , 2007, The British journal of surgery.

[26]  H. Ojima,et al.  Clinical impact of the surgical margin status in hepatectomy for solitary mass‐forming type intrahepatic cholangiocarcinoma without lymph node metastases , 2007, Journal of surgical oncology.

[27]  E. Hatano,et al.  Implication of Frequent Local Ablation Therapy for Intrahepatic Recurrence in Prolonged Survival of Patients With Hepatocellular Carcinoma Undergoing Hepatic Resection: An Analysis of 610 Patients Over 16 Years Old , 2006, Annals of surgery.

[28]  Report of the 15th follow-up survey of primary liver cancer. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  W. Grigioni,et al.  The Role of Lymphadenectomy for Liver Tumors: Further Considerations on the Appropriateness of Treatment Strategy , 2004, Annals of surgery.

[30]  F. Romano,et al.  Hepatic Surgery Using the Ligasure Vessel Sealing System , 2004, World Journal of Surgery.

[31]  M. Miyazaki,et al.  Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival , 2002, The British journal of surgery.

[32]  Michael A. Choti,et al.  Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.

[33]  H. Kinoshita,et al.  Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma. , 2002, Journal of hepato-biliary-pancreatic surgery.

[34]  M. Makuuchi,et al.  A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.

[35]  H. Kinoshita,et al.  Clinicopathological factors predicting outcome after resection of mass‐forming intrahepatic cholangiocarcinoma , 2001, The British journal of surgery.

[36]  H. Shimoji,et al.  Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. , 2001, American journal of surgery.

[37]  S. Kawasaki,et al.  Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. , 2000, Surgery.

[38]  S. Isaji,et al.  Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. , 1999, Journal of hepato-biliary-pancreatic surgery.

[39]  O. Farges,et al.  Resection of intrahepatic cholangiocarcinoma: a Western experience. , 1999, Journal of hepato-biliary-pancreatic surgery.

[40]  Randall G. Lee,et al.  Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma , 1997 .

[41]  A. Rahmouni,et al.  Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. , 1995, Archives of surgery.

[42]  Y. Konishi,et al.  Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma , 1994, Journal of gastroenterology and hepatology.

[43]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.